Clinical Trial Update: Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)

View source ↗

Summary

Real-life follow-up study of cystic fibrosis patients treated with the Ivacaftor+Lumacaftor combination (Orkambi) has completed, reporting outcomes from routine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Kalydeco (ivacaftor)
• ORKAMBI (lumacaftor and ivacaftor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | Status: COMPLETED